Paper32017286
Tumor immune microenvironment in head and neck cancers.
Chen SMY and 5 others. Mol Carcinog, 2020. Cited by 153 papers, by iCite.
Cite this record
ConductScience Library. Tumor immune microenvironment in head and neck cancers. Papers, record 32017286. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32017286
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Head and Neck Neoplasms | Major topic |
| Tumor Microenvironment | Major topic |
| Animals | |
| Cell Transformation, Neoplastic | |
| Humans | |
| Immunotherapy | |
| Squamous Cell Carcinoma of Head and Neck |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| F31 DE027854 | NIDCR NIH HHS | United States | F31DE027854 | PubMed and NIH | NIH RePORTER |
| T32 AI007405 | NIAID NIH HHS | United States | T32AI007405 | PubMed and NIH | NIH RePORTER |
| T32 CA174648 | NCI NIH HHS | United States | T32CA174648 | PubMed | NIH RePORTER |
| R01 DE028420 | NIDCR NIH HHS | United States | R01DE028420 | PubMed and NIH | NIH RePORTER |
| R01 DE027329 | NIDCR NIH HHS | United States | R01DE027329 | PubMed and NIH | NIH RePORTER |
References130
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29147608 | The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis. | Oncoimmunology | 2017 | https://conductscience.org/library/papers/29147608 | PubMed |
| 2 | 27956380 | Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade. | Cancer Immunol Res | 2017 | https://conductscience.org/library/papers/27956380 | PubMed |
| 3 | 29563330 | CD38+ M-MDSC expansion characterizes a subset of advanced colorectal cancer patients. | JCI Insight | 2018 | https://conductscience.org/library/papers/29563330 | PubMed |
| 4 | 28811959 | T-helper and T-regulatory cells modulation in head and neck squamous cell carcinoma. | Oncoimmunology | 2017 | https://conductscience.org/library/papers/28811959 | PubMed |
| 5 | 19183242 | Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck. | J Cell Mol Med | 2010 | https://conductscience.org/library/papers/19183242 | PubMed |
| 6 | 25428507 | Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. | Nature | 2014 | https://conductscience.org/library/papers/25428507 | PubMed |
| 7 | 25837513 | Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. | Science | 2015 | https://conductscience.org/library/papers/25837513 | PubMed |
| 8 | 22313874 | Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression. | Semin Cancer Biol | 2012 | https://conductscience.org/library/papers/22313874 | PubMed |
| 9 | 27718784 | Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27718784 | PubMed |
| 10 | 26168215 | Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected. | J Clin Invest | 2015 | https://conductscience.org/library/papers/26168215 | PubMed |
| 11 | 26089604 | Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms. | Mediators Inflamm | 2015 | https://conductscience.org/library/papers/26089604 | PubMed |
| 12 | 27265504 | CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma. | Cancer Cell | 2016 | https://conductscience.org/library/papers/27265504 | PubMed |
| 13 | 28115575 | The EGR2 targets LAG-3 and 4-1BB describe and regulate dysfunctional antigen-specific CD8+ T cells in the tumor microenvironment. | J Exp Med | 2017 | https://conductscience.org/library/papers/28115575 | PubMed |
| 14 | 28650338 | IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade. | J Clin Invest | 2017 | https://conductscience.org/library/papers/28650338 | PubMed |
| 15 | 28491874 | Innate-Adaptive Immune Crosstalk 2016. | J Immunol Res | 2017 | https://conductscience.org/library/papers/28491874 | PubMed |
| 16 | 31308358 | Clinical update on head and neck cancer: molecular biology and ongoing challenges. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/31308358 | PubMed |
| 17 | 27339708 | The role of myeloid cells in cancer therapies. | Nat Rev Cancer | 2016 | https://conductscience.org/library/papers/27339708 | PubMed |
| 18 | 24935016 | Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances. | Nat Rev Clin Oncol | 2014 | https://conductscience.org/library/papers/24935016 | PubMed |
| 19 | 16034368 | Cancer/testis antigens, gametogenesis and cancer. | Nat Rev Cancer | 2005 | https://conductscience.org/library/papers/16034368 | PubMed |
| 20 | 29254756 | Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells. | Semin Immunol | 2018 | https://conductscience.org/library/papers/29254756 | PubMed |
Cited by116
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 153 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42618717 | Tumor-derived PTX3 drives an immunosuppressive myeloid landscape and inhibits CD8 T cell-mediated anti-tumor immunity via PI3K-dependent signaling. | Oncogene | 2026 | https://conductscience.org/library/papers/42618717 | PubMed |
| 42614551 | Single-cell RNA sequencing reveals hypoxia-associated stress response signatures in the immune and stromal microenvironment of laryngeal squamous cell carcinoma. | Front Immunol | 2026 | https://conductscience.org/library/papers/42614551 | PubMed |
| 42414478 | Single nucleus RNA profiling reveals potential therapeutic vulnerabilities in sinonasal carcinomas. | NPJ Precis Oncol | 2026 | https://conductscience.org/library/papers/42414478 | PubMed |
| 42292754 | Prognostic Impact and Clinicopathological Significance of TIM-3 and LAG-3 Expressions in Laryngeal Squamous Cell Carcinoma. | Laryngoscope Investig Otolaryngol | 2026 | https://conductscience.org/library/papers/42292754 | PubMed |
| 42265804 | Multifactorial effects of LGALS1 blockade sensitize tumors to immune checkpoint inhibitor. | Exp Hematol Oncol | 2026 | https://conductscience.org/library/papers/42265804 | PubMed |
| 42221217 | Development of a Prognostic Nomogram Model and Establishment of a Risk Stratification System Based on the Naples Prognostic Score for Patients with Oropharyngeal Squamous Cell Carcinoma Who Have Undergone Radical Surgery. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42221217 | PubMed |
| 42185849 | Targeting the NKG2D axis in head and neck squamous cell carcinoma: from molecular insights to clinical applications. | Cancer Cell Int | 2026 | https://conductscience.org/library/papers/42185849 | PubMed |
| 41993185 | Red-complex bacteria: immunological background leading to the development of head and neck cancers. | Front Immunol | 2026 | https://conductscience.org/library/papers/41993185 | PubMed |
| 41929629 | Multi-omics analysis identifies CLDN10 as a B-cell-associated prognostic biomarker in HPV-negative head and neck squamous cell carcinoma. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/41929629 | PubMed |
| 41879001 | LILRB1 Is a Prognostic-Related Biomarker Correlated With Immune Infiltration in Head-Neck Squamous Cell Carcinoma. | Cancer Med | 2026 | https://conductscience.org/library/papers/41879001 | PubMed |
| 41713051 | Hydrogels in head and neck cancer: Innovations and translational advances in research and therapy. | Biomaterials | 2026 | https://conductscience.org/library/papers/41713051 | PubMed |
| 41710363 | Next Generation Calcium Nanomaterials: Disrupting Tumor Ca2⁺ Homeostasis for Enhanced Cancer Therapy. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/41710363 | PubMed |
| 41627880 | Driving progress in recurrent and metastatic head and neck cancer: the NRG Oncology perspective. | J Natl Cancer Inst | 2026 | https://conductscience.org/library/papers/41627880 | PubMed |
| 41624538 | NIR-II biomimetic nanoplatform optogenetic CD274 editing of HNSCC immunogenicity for enhanced photoimmunotherapy. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41624538 | PubMed |
| 41614901 | Role of the Super-Enhancer Component Bromodomain Protein 4 in the Radiation Response of Human Head and Neck Squamous Cell Carcinoma Cells. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/41614901 | PubMed |
| 41588455 | Analysis of the efficacy of camrelizumab/cetuximab neoadjuvant therapy in patients with loco-regionally advanced laryngeal and hypopharyngeal cancer and the prognostic value of NLR/SII. | World J Surg Oncol | 2026 | https://conductscience.org/library/papers/41588455 | PubMed |
| 41585201 | Ovatodiolide overcomes cisplatin resistance in head and neck cancer by disrupting a novel oncogenic signature and cancer-associated fibroblast activation. | J Dent Sci | 2026 | https://conductscience.org/library/papers/41585201 | PubMed |
| 41225107 | Characterizing the Head and Neck Cancer Microenvironment: Implications for Immunotherapy and Prognosis. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/41225107 | PubMed |
| 40910245 | Nano-Engineered Cetuximab-Copper Complexes for Targeted Drug Delivery in Head and Neck Cancer. | Curr Drug Deliv | 2026 | https://conductscience.org/library/papers/40910245 | PubMed |
| 40864763 | Molecular Targets for Pharmacotherapy of Head and Neck Squamous Cell Carcinomas. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40864763 | PubMed |
Genes36
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32017286
GET https://conductscience.org/api/papers/v1/32017286/references?page=2